IDEAS home Printed from https://ideas.repec.org/f/pme908.html
   My authors  Follow this author

Susan Johanna Mendez

Personal Details

First Name:Susan
Middle Name:Johanna
Last Name:Mendez
Suffix:
RePEc Short-ID:pme908
http://sites.google.com/site/susanjmendez/
Twitter: @susanjmendez

Affiliation

Melbourne Institute of Applied Economic and Social Research (MIAESR)
Faculty of Business and Economics
University of Melbourne

Melbourne, Australia
http://www.melbourneinstitute.com/
RePEc:edi:mimelau (more details at EDIRC)

Research output

as
Jump to: Working papers Articles

Working papers

  1. Susan J. Méndez, 2016. "Parallel Trade of Pharmaceuticals: The Danish Market for Statins," Melbourne Institute Working Paper Series wp2016n08, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
  2. Moshe Justman & Susan J. Méndez, 2016. "Gendered Selection of STEM Subjects for Matriculation," Melbourne Institute Working Paper Series wp2016n10, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
  3. Ulrich Kaiser & Susan J. Méndez, 2015. "How Do Drug Prices Respond to a Change from External to Internal Reference Pricing? Evidence from a Danish Regulatory Reform," Melbourne Institute Working Paper Series wp2015n04, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.
  4. Ulrich Kaiser & Susan J. Mendez & Thomas Rønde, 2010. "Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark," CIE Discussion Papers 2010-01, University of Copenhagen. Department of Economics. Centre for Industrial Economics.

Articles

  1. Méndez, Susan J. & Scott, Anthony & Zhang, Yuting, 2021. "Gender differences in physician decisions to adopt new prescription drugs," Social Science & Medicine, Elsevier, vol. 277(C).
  2. Justman, Moshe & Méndez, Susan J., 2018. "Gendered choices of STEM subjects for matriculation are not driven by prior differences in mathematical achievement," Economics of Education Review, Elsevier, vol. 64(C), pages 282-297.
  3. Susan J. Méndez, 2018. "Parallel trade of pharmaceuticals: The Danish market for statins," Health Economics, John Wiley & Sons, Ltd., vol. 27(2), pages 333-356, February.
  4. Kaiser, Ulrich & Mendez, Susan J. & Rønde, Thomas & Ullrich, Hannes, 2014. "Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark," Journal of Health Economics, Elsevier, vol. 36(C), pages 174-187.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Moshe Justman & Susan J. Méndez, 2016. "Gendered Selection of STEM Subjects for Matriculation," Melbourne Institute Working Paper Series wp2016n10, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.

    Cited by:

    1. Huong Thu Le & Ha Trong Nguyen, 2018. "The evolution of the gender test score gap through seventh grade: new insights from Australia using unconditional quantile regression and decomposition," IZA Journal of Labor Economics, Springer;Forschungsinstitut zur Zukunft der Arbeit GmbH (IZA), vol. 7(1), pages 1-42, December.
    2. Rapoport, Benoît & Thibout, Claire, 2018. "Why do boys and girls make different educational choices? The influence of expected earnings and test scores," Economics of Education Review, Elsevier, vol. 62(C), pages 205-229.

  2. Ulrich Kaiser & Susan J. Méndez, 2015. "How Do Drug Prices Respond to a Change from External to Internal Reference Pricing? Evidence from a Danish Regulatory Reform," Melbourne Institute Working Paper Series wp2015n04, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne.

    Cited by:

    1. Granlund, David & Bergman, Mats A., 2018. "Price competition in pharmaceuticals – Evidence from 1303 Swedish markets," Journal of Health Economics, Elsevier, vol. 61(C), pages 1-12.

  3. Ulrich Kaiser & Susan J. Mendez & Thomas Rønde, 2010. "Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark," CIE Discussion Papers 2010-01, University of Copenhagen. Department of Economics. Centre for Industrial Economics.

    Cited by:

    1. David Bardey & Arturo Harker & Daniela Zuluaga, 2021. "Price cap regulation in the Colombian pharmaceutical market: An impact evaluation," Documentos CEDE 019117, Universidad de los Andes - CEDE.
    2. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    3. Mats A. Bergman & David Granlund & Niklas Rudholm, 2016. "Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose," International Journal of Health Economics and Management, Springer, vol. 16(3), pages 201-214, September.
    4. Brekke, Kurt R. & Canta, Chiara & Straume, Odd Rune, 2015. "Does Reference Pricing Drive Out Generic Competition in Pharmaceutical Markets? Evidence from a Policy Reform," Discussion Paper Series in Economics 11/2015, Norwegian School of Economics, Department of Economics.
    5. Susan J. Méndez, 2018. "Parallel trade of pharmaceuticals: The Danish market for statins," Health Economics, John Wiley & Sons, Ltd., vol. 27(2), pages 333-356, February.
    6. David Granlund & Miyase Koksal-Ayhan, 2015. "Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(9), pages 969-983, December.
    7. Niels Skipper & Rune Vejlin, 2013. "Determinants of Generic vs. Brand Drug Choice: Evidence from Population-wide Danish Data," Economics Working Papers 2013-05, Department of Economics and Business Economics, Aarhus University.
    8. Foad Iravani & Hamed Mamani & Emisa Nategh, 2020. "External Reference Pricing and Parallel Imports of Pharmaceuticals: A Policy Comparison," Production and Operations Management, Production and Operations Management Society, vol. 29(12), pages 2716-2735, December.
    9. Kurt R. Brekke & Tor Helge Holmås & Odd Rune Straume, 2010. "Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment," CESifo Working Paper Series 3258, CESifo.
    10. Duso, T. & Herr, A. & Suppliet, M, 2014. "The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics," Health, Econometrics and Data Group (HEDG) Working Papers 14/09, HEDG, c/o Department of Economics, University of York.
    11. Hauschultz, Frederik Plum & Munk-Nielsen, Anders, 2020. "Markups on Drop-Downs: Prominence in Pharmaceutical Markets∗," MPRA Paper 104582, University Library of Munich, Germany.
    12. Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-034, Tilburg University, Tilburg Law and Economic Center.
    13. Kaiser, Ulrich & Mendez, Susan J., 2015. "How do drug prices respond to a change from external to internal reference pricing? Evidence from a Danish regulatory reform," ZEW Discussion Papers 15-004, ZEW - Leibniz Centre for European Economic Research.
    14. Birg, Laura, 2019. "Reference Pricing and Parallel Imports: Evidence from Germany," VfS Annual Conference 2019 (Leipzig): 30 Years after the Fall of the Berlin Wall - Democracy and Market Economy 203666, Verein für Socialpolitik / German Economic Association.
    15. Timothy T. Brown & James C. Robinson, 2016. "Reference Pricing with Endogenous or Exogenous Payment Limits: Impacts on Insurer and Consumer Spending," Health Economics, John Wiley & Sons, Ltd., vol. 25(6), pages 740-749, June.
    16. Kurt R. Brekke & Chiara Canta & Odd Rune Straume, 2015. "Reference pricing with endogenous generic entry," NIPE Working Papers 2/2015, NIPE - Universidade do Minho.
    17. Pamina Koenig & Megan Macgarvie, 2011. "Regulatory policy and the location of bio-pharmaceutical foreign direct investment in Europe," Post-Print halshs-00754522, HAL.
    18. Nazila Yousefi & Mahyar Polroudi Moghaddam & Gita Afsharmanesh & Farzad Peiravian, 2020. "Evaluation of efficiency enhancement in Iran Health Insurance Organization: a policy brief for pharmaceutical cost containment," International Journal of Health Planning and Management, Wiley Blackwell, vol. 35(6), pages 1503-1511, November.
    19. Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.
    20. Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
    21. Gregory J. Critchley & Gregory S. Zaric, 2019. "The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare," Health Economics, John Wiley & Sons, Ltd., vol. 28(8), pages 1035-1051, August.
    22. Sebastian Linde & Brandon Norton & Ralph Siebert, 2019. "The Effect of Bargaining Power Determinants on Pharmaceutical Prices," CESifo Working Paper Series 7988, CESifo.
    23. Ivan Moreno-Torres, 2011. "What if there was a stronger pharmaceutical price competition in Spain? When regulation has a similar effect to collusion," Working Papers XREAP2011-02, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    24. Ivan Moreno-Torres, 2011. "Generic drugs in Spain: price competition vs. moral hazard," Working Papers XREAP2011-04, Xarxa de Referència en Economia Aplicada (XREAP), revised May 2011.
    25. Dominik J. Wettstein & Stefan Boes, 2019. "Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review," Applied Health Economics and Health Policy, Springer, vol. 17(2), pages 143-162, April.
    26. Stadhouders, Niek & Kruse, Florien & Tanke, Marit & Koolman, Xander & Jeurissen, Patrick, 2019. "Effective healthcare cost-containment policies: A systematic review," Health Policy, Elsevier, vol. 123(1), pages 71-79.
    27. Herr, Annika & Stühmeier, Torben & Wenzel, Tobias, 2014. "Reference pricing and cost-sharing: Theory and evidence on German off-patent drugs," VfS Annual Conference 2014 (Hamburg): Evidence-based Economic Policy 100556, Verein für Socialpolitik / German Economic Association.

Articles

  1. Méndez, Susan J. & Scott, Anthony & Zhang, Yuting, 2021. "Gender differences in physician decisions to adopt new prescription drugs," Social Science & Medicine, Elsevier, vol. 277(C).

    Cited by:

    1. Melissa Newham & Marica Valente, 2022. "Who pays for gifts to physicians? Heterogeneous effects of industry payments on drug costs," Papers 2203.01778, arXiv.org.

  2. Justman, Moshe & Méndez, Susan J., 2018. "Gendered choices of STEM subjects for matriculation are not driven by prior differences in mathematical achievement," Economics of Education Review, Elsevier, vol. 64(C), pages 282-297.

    Cited by:

    1. Ainoa Aparicio Fenoll & Sarah Zaccagni, 2021. "Gender Mix and Team Performance: Differences between Exogenously and Endogenously Formed Teams," Carlo Alberto Notebooks 646, Collegio Carlo Alberto.
    2. Izaskun Zuazu, 2020. "Graduates’ Opium? Cultural Values, Religiosity and Gender Segregation by Field of Study," Social Sciences, MDPI, vol. 9(8), pages 1-27, July.
    3. Delaney, Judith M. & Devereux, Paul J., 2019. "Understanding gender differences in STEM: Evidence from college applications✰," Economics of Education Review, Elsevier, vol. 72(C), pages 219-238.
    4. Biewen, Martin & Schwerter, Jakob, 2019. "Does More Math in High School Increase the Share of Female STEM Workers? Evidence from a Curriculum Reform," IZA Discussion Papers 12236, Institute of Labor Economics (IZA).
    5. Marcos Agurto & Sandra Buzinsky & Siddharth Hari & Valeria Quevedo & Sudipta Sarangi & Susana Vegas, 2020. "Academic Aptitude Signals and STEM field participation: A Regression Discontinuity Approach," Working Papers 2020-08, Lima School of Economics.
    6. Naomi Friedman-Sokuler & Moshe Justman, 2019. "Gender, Culture and STEM: Counter-Intuitive Patterns in Arab Society," Working Papers 2019-02, Bar-Ilan University, Department of Economics.
    7. Naomi Friedman-Sokuler & Claudia Senik, 2020. "From Pink-Collar to Lab Coat. Cultural Persistence and Diffusion of Socialist Gender Norms," Working Papers halshs-02872229, HAL.
    8. Thelwall, Mike & Bailey, Carol & Tobin, Catherine & Bradshaw, Noel-Ann, 2019. "Gender differences in research areas, methods and topics: Can people and thing orientations explain the results?," Journal of Informetrics, Elsevier, vol. 13(1), pages 149-169.
    9. Ainoa Aparicio Fenoll & Flavia Coda-Moscarola & Sarah Zaccagni, 2021. "Mathematics Camps: A Gift for Gifted Students," Carlo Alberto Notebooks 647, Collegio Carlo Alberto.
    10. Fernando Saltiel, 2019. "What's Math Got to Do With It? Multidimensional Ability and the Gender Gap in STEM," 2019 Meeting Papers 1201, Society for Economic Dynamics.
    11. Bordón, Paola & Canals, Catalina & Mizala, Alejandra, 2020. "The gender gap in college major choice in Chile," Economics of Education Review, Elsevier, vol. 77(C).
    12. Zuazu-Bermejo, Izaskun, 2020. "Graduates’ opium? Cultural values, religiosity and gender segregation by field of study," OSF Preprints yn23j, Center for Open Science.

  3. Kaiser, Ulrich & Mendez, Susan J. & Rønde, Thomas & Ullrich, Hannes, 2014. "Regulation of pharmaceutical prices: Evidence from a reference price reform in Denmark," Journal of Health Economics, Elsevier, vol. 36(C), pages 174-187.
    See citations under working paper version above.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 9 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-REG: Regulation (7) 2010-09-11 2010-11-13 2013-03-23 2014-02-02 2015-01-26 2015-02-11 2015-02-22. Author is listed
  2. NEP-COM: Industrial Competition (4) 2010-09-11 2010-11-13 2013-03-23 2016-03-23
  3. NEP-HEA: Health Economics (4) 2010-09-11 2013-03-23 2014-02-02 2016-03-23
  4. NEP-EUR: Microeconomic European Issues (2) 2010-11-13 2013-03-23
  5. NEP-MKT: Marketing (2) 2013-03-23 2014-02-02
  6. NEP-EDU: Education (1) 2016-03-23

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Susan Johanna Mendez should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.